These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38935068)

  • 21. Scoring functions for drug-effect similarity.
    Struckmann S; Ernst M; Fischer S; Mah N; Fuellen G; Möller S
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32484516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug repurposing: Iron in the fire for older drugs.
    Sonaye HV; Sheikh RY; Doifode CA
    Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dex-Benchmark: datasets and code to evaluate algorithms for transcriptomics data analysis.
    Xie Z; Chen C; Ma'ayan A
    PeerJ; 2023; 11():e16351. PubMed ID: 37953774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities.
    Shah I; Bundy J; Chambers B; Everett LJ; Haggard D; Harrill J; Judson RS; Nyffeler J; Patlewicz G
    Chem Res Toxicol; 2022 Nov; 35(11):1929-1949. PubMed ID: 36301716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Bayesian approach to accurate and robust signature detection on LINCS L1000 data.
    Qiu Y; Lu T; Lim H; Xie L
    Bioinformatics; 2020 May; 36(9):2787-2795. PubMed ID: 32003771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GeneExpressionSignature: an R package for discovering functional connections using gene expression signatures.
    Li F; Cao Y; Han L; Cui X; Xie D; Wang S; Bo X
    OMICS; 2013 Feb; 17(2):116-8. PubMed ID: 23374109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel computational approach for drug repurposing using systems biology.
    Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
    Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topological benchmarking of algorithms to infer gene regulatory networks from single-cell RNA-seq data.
    Stock M; Popp N; Fiorentino J; Scialdone A
    Bioinformatics; 2024 May; 40(5):. PubMed ID: 38627250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HGTDR: Advancing drug repurposing with heterogeneous graph transformers.
    Gharizadeh A; Abbasi K; Ghareyazi A; Mofrad MRK; Rabiee HR
    Bioinformatics; 2024 Jul; 40(7):. PubMed ID: 38913860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A network-based drug repurposing method via non-negative matrix factorization.
    Sadeghi S; Lu J; Ngom A
    Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benchmarking network propagation methods for disease gene identification.
    Picart-Armada S; Barrett SJ; Willé DR; Perera-Lluna A; Gutteridge A; Dessailly BH
    PLoS Comput Biol; 2019 Sep; 15(9):e1007276. PubMed ID: 31479437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering.
    Wang F; Ding Y; Lei X; Liao B; Wu FX
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):953-965. PubMed ID: 32845842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing.
    Chan J; Wang X; Turner JA; Baldwin NE; Gu J
    Bioinformatics; 2019 Aug; 35(16):2818-2826. PubMed ID: 30624606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From gene networks to drugs: systems pharmacology approaches for AUD.
    Ferguson LB; Harris RA; Mayfield RD
    Psychopharmacology (Berl); 2018 Jun; 235(6):1635-1662. PubMed ID: 29497781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signature-based approaches for informed drug repurposing: targeting CNS disorders.
    Shukla R; Henkel ND; Alganem K; Hamoud AR; Reigle J; Alnafisah RS; Eby HM; Imami AS; Creeden JF; Miruzzi SA; Meller J; Mccullumsmith RE
    Neuropsychopharmacology; 2021 Jan; 46(1):116-130. PubMed ID: 32604402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug target prediction and repositioning using an integrated network-based approach.
    Emig D; Ivliev A; Pustovalova O; Lancashire L; Bureeva S; Nikolsky Y; Bessarabova M
    PLoS One; 2013; 8(4):e60618. PubMed ID: 23593264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MIDGET:Detecting differential gene expression on microarray data.
    Angelescu R; Dobrescu R
    Comput Methods Programs Biomed; 2021 Nov; 211():106418. PubMed ID: 34555591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.